{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:16:12Z","timestamp":1715213772344},"reference-count":21,"publisher":"The Japan Geriatrics Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nippon Ronen Igakkai Zasshi","Nihon Ronen Igakkai Zasshi","Jpn J Geriat","Jpn. j. geriat"],"published-print":{"date-parts":[[2021,10,25]]},"DOI":"10.3143\/geriatrics.58.624","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T22:09:18Z","timestamp":1638914958000},"page":"624-629","source":"Crossref","is-referenced-by-count":1,"title":["A case of meningoencephalitis that developed during nivolumab use","\u514d\u75ab\u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u963b\u5bb3\u85ac\u306e\u95a2\u9023\u304c\u793a\u5506\u3055\u308c\u305f\u9ac4\u819c\u8133\u708e\u306e1\u4f8b"],"prefix":"10.3143","volume":"58","author":[{"given":"Yu","family":"Suzuki","sequence":"first","affiliation":[{"name":"Division of Neurology, Department of Internal Medicine, St Marianna University School of Medicine"},{"name":"Department of Neurology, Shinyurigaoka General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenzo","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Internal Medicine, St Marianna University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Uchino","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Internal Medicine, St Marianna University School of Medicine"},{"name":"Division of Neurology, Department of Internal Medicine, Kawasaki Municipal Tama Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Inoue","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, St Marianna University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Takahashi","sequence":"additional","affiliation":[{"name":"National Epilepsy Center, NHO Shizuoka Institute of Epilepsy and Neurological Disorders"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Internal Medicine, St Marianna University School of Medicine"},{"name":"Department of Neurology, Shinyurigaoka General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Yamano","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Internal Medicine, St Marianna University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1704","reference":[{"key":"1","unstructured":"1) \u9234\u6728\u91cd\u660e: \u514d\u75ab\u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u963b\u5bb3\u85ac\u3068\u795e\u7d4c\u30fb\u7b4b\u75be\u60a3. Annual Review \u795e\u7d4c, \u4e2d\u5916\u533b\u5b66\u793e, \u6771\u4eac, 2018, p281-286."},{"key":"2","doi-asserted-by":"publisher","unstructured":"2) \u72ac\u585a \u8cb4, \u6797 \u7950\u4e00, \u6728\u6751\u6681\u592b: \u508d\u816b\u760d\u795e\u7d4c\u75c7\u5019\u7fa4. \u81e8\u5e8a\u795e\u7d4c\u5b66 2011; 51: 834-837.","DOI":"10.5692\/clinicalneurol.51.834"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al.: Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004; 75: 1135-1140.","DOI":"10.1136\/jnnp.2003.034447"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Cuzzubbo S, Javeri F, Tissier M, Roumi A, Barlog C, Doridam J, et al.: Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature. Eur J Cancer 2017; 73: 1-8.","DOI":"10.1016\/j.ejca.2016.12.001"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Eltobgy M, Oweira H, Petrausch U, Helbling D, Schmidt J, Mehrabi A, et al.: Immune-related neurological toxicities among solid tumor patients treated with immune checkpoint inhibitors: a systematic review. Expert Rev Neurother 2017; 17: 725-736.","DOI":"10.1080\/14737175.2017.1336088"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Gonzalez NL, Puwanant A, Lu A, Marks SM, \u017divkovi\u0107 SA: Myasthenia triggered by immune checkpoint inhibitors: New case and literature review. Neuromuscul Disord 2017; 27: 266-268.","DOI":"10.1016\/j.nmd.2017.01.002"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Hottinger AF: Neurologic complications of immune checkpoint inhibitors. Curr Opin Neurol 2016; 29: 806-812.","DOI":"10.1097\/WCO.0000000000000391"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Larkin J, Chmielowski B, Lao CD, Hodi FS, Sharfman W, Weber J, et al.: Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis. Oncologist 2017; 22: 709-718.","DOI":"10.1634\/theoncologist.2016-0487"},{"key":"9","unstructured":"9) \u65e5\u672c\u80ba\u764c\u5b66\u4f1a\u7de8: \u80ba\u764c\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f32017\u7248IV\u671f\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u85ac\u7269\u7642\u6cd5, \u91d1\u539f\u51fa\u7248, \u6771\u4eac, 2017, p36-39."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Borghaei H, Ares LP, Horn L, Spigel DR, Steins M, Ready NE, et al.: Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer. N Engl J Med 2015; 373: 1627-1639.","DOI":"10.1056\/NEJMoa1507643"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Leitinger M, Varosanec MV, Pikija S, Wass RE, Bandke D, Weis S, et al.: Fatal necrotizing encephalopathy after treatment with nivolumab for squamous non-small cell lung cancer: Case Report and Review of the Literature. Front Immunol 2018; 9: 108.","DOI":"10.3389\/fimmu.2018.00108"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Schneider S, Potthast S, Komminoth P, Schwegler G, B\u00f6hm S: PD-1 checkpoint inhibitor associated autoimmune encephalitis. Case Rep Oncol 2017; 10: 473-478.","DOI":"10.1159\/000477162"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Williams TJ, Benavides DR, Patrice KA, Dalmau JO, Ribeiro de \u00c1vila AL, Le DT, et al.: Association of autoimmune encephalitis with combined immune checkpoint inhibitor treatment for metastatic cancer. JAMA Neurol 2016; 73: 928-933.","DOI":"10.1001\/jamaneurol.2016.1399"},{"key":"14","unstructured":"14) \u7530\u4e2d\u6075\u5b50: \u8133\u75c7\u30fb\u8133\u708e\u3092\u751f\u3058\u308b\u508d\u816b\u760d\u6027\u795e\u7d4c\u75c7\u6027\u5019\u7fa4. \u795e\u7d4c\u6cbb\u7642 2009; 26: 31-37."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J: Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 Patients. Brain 2000; 123: 1481-1494.","DOI":"10.1093\/brain\/123.7.1481"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16) \u5897\u7530\u66dc\u7ae0, \u6728\u6751\u6210\u5fd7, \u77f3\u6a4b\u6b63\u4eba, \u4f0a\u6771\u771f\u77e5\u5b50, \u9ad8\u6a4b\u5e78\u5229, \u718a\u672c\u4fca\u79c0: \u9ac4\u6db2\u6297\u30b0\u30eb\u30bf\u30df\u30f3\u9178\u53d7\u5bb9\u4f53\u03b52\u6297\u4f53\u967d\u6027\u306e\u975e\u30d8\u30eb\u30da\u30b9\u6027\u6025\u6027\u8fba\u7e01\u7cfb\u8133\u708e\u3092\u3068\u3082\u306a\u3063\u305fVogt-\u5c0f\u67f3-\u539f\u7530\u75c5\u306e1\u4f8b. \u81e8\u5e8a\u795e\u7d4c\u5b66 2009; 49: 483-487.","DOI":"10.5692\/clinicalneurol.49.483"},{"key":"17","first-page":"629","volume":"47","year":"2007","unstructured":"17) \u65b0\u5802\u6643\u5927, \u4f0a\u4e95\u88d5\u4e00\u90ce, \u4f50\u3005\u6728\u826f\u5143, \u9ad8\u6a4b\u5e78\u5229, \u7c73\u7530 \u8aa0, \u845b\u539f\u8302\u6a39: \u8840\u6e05\u3068\u9ac4\u6db2\u4e2d\u306e\u6297\u30b0\u30eb\u30bf\u30df\u30f3\u9178\u53d7\u5bb9\u4f53\u03b52\u6297\u4f53\u304c\u967d\u6027\u3067\u975e\u30d8\u30eb\u30da\u30b9\u6027\u6025\u6027\u8fba\u7e01\u7cfb\u8133\u708e\u69d8\u306e\u75c7\u72b6\u3092\u5448\u3057\u305f\u6a4b\u672c\u8133\u75c7\u306e1\u4f8b. \u81e8\u5e8a\u795e\u7d4c\u5b66 2007; 47: 629-634.","journal-title":"Rinsho Shinkeigaku","ISSN":"http:\/\/id.crossref.org\/issn\/0009-918X","issn-type":"print"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) \u5c71\u53e3\u4f73\u525b, \u548c\u7530 \u5b66, \u6817\u7530\u5553\u53f8, \u9ad8\u6a4b\u5e78\u5229, \u52a0\u85e4\u4e08\u592b: SLE\u3092\u80cc\u666f\u3068\u3057, \u75c5\u614b\u306b\u6297\u30b0\u30eb\u30bf\u30df\u30f3\u9178\u53d7\u5bb9\u4f53\u6297\u4f53\u306e\u95a2\u4e0e\u304c\u793a\u5506\u3055\u308c\u305f\u81ea\u5df1\u514d\u75ab\u75be\u60a3\u95a2\u9023\u6027\u8fba\u7e01\u7cfb\u8133\u708e\u306e1\u4f8b. \u81e8\u5e8a\u795e\u7d4c 2012; 52: 545-550.","DOI":"10.5692\/clinicalneurol.52.545"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Cabral G, Ladeira F, Gil N: Nivolumab-induced seronegative encephalitis. J Neuroimmunology 2020; 347: 577350.","DOI":"10.1016\/j.jneuroim.2020.577350"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Takahashi Y, Nishimura S, Takao E, Kasai R, Enokida K, Ida K: Characteristics of internalization of NMDA-type GluRs with antibodies to GluN1 and GluN2B. J Neuroimmunology 2020; 349: 577427.","DOI":"10.1016\/j.jneuroim.2020.577427"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Gill A, Perez MA, Perrone CM, Bae CJ, Pruitt AA, Lancaster E: A case series of PD-1 inhibitor-associated paraneoplastic neurologic syndromes. J Neuroimmunology 2019; 334: 576980.","DOI":"10.1016\/j.jneuroim.2019.576980"}],"container-title":["Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/geriatrics\/58\/4\/58_58.624\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T05:25:18Z","timestamp":1715145918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/geriatrics\/58\/4\/58_58.624\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,25]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.3143\/geriatrics.58.624","relation":{},"ISSN":["0300-9173"],"issn-type":[{"value":"0300-9173","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,25]]},"article-number":"58.624"}}